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IL-2 secretion in total or subsets of PHA/PMA-stimulated
PBMC-derived human T-lymphocytes was monitored and
found to be largely due to CD4/CD8- cells. The presence
and functional state of transcription factors (TF) was
assessed by protein-DNA interaction assays and functional
transactivation experiments in the Xenopts oocyte system,
modulating IL-2 transcription by injection of proteins.
The results reveal that CD4/CD8 cells contain both,
functional silencer in their resting, and positive TF in their
activated states while the CD8+CD4- group contains only
non-functional positive TF. This demonstrates that the
on/off switch of IL-2 transcription is based on the same
mechanism in primary T-lymphocytes of mouse spleen
and in peripheral human CD4/CD8- cells.
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Introduction
The IL-2 gene is uniquely expressed in stimulated
T-cells and its translation product plays a major role
in T-cell proliferation. The induction of the IL-2
gene is mediated by a transcriptional enhancer
spanning about 300 bp upstream of the cap site
(review in Ref. 1). A key promoter element for the
tissue-specific transcriptional activation of the IL-2
gene is a purine-rich box (Pud) extending, in the
human promoter, from --290 to --263 nucleo-
tides.1 This region is the NF-AT-binding site.
3 If
incubated in vitro with protein extracts from mouse
2
or human
3 cell lines, it binds a protein which seems
to be a positive transcription factor (T.F) as it is
present in activated cells only.
Using protein extracts from primary mouse
splenic T-cells, we were able to show that two
different proteins bind to this region at different
activity phases of the protein-donor cells. Using
functional assays in the Xenopus laevis oocyte system,
we demonstrated that in resting T-cells the protein
which binds to the Pud box is a silencer that
represses the basal activity of the IL-2 gene. In
mitogen-induced cells a positive TF binds to the
same promoter element and efficiently derepresses
IL-2 transcription.
4
In the present study we compared IL-2 secretion
by subsets of resting and mitogen-induced human
peripheral blood T-cells with the presence and
functional state of TFs regulating IL-2 expression.
Besides illustrating the resemblance of the regu-
latory mechanism in mouse and human cells, the
results indicate that only CD4+CD8- cells
possess a fully functional IL-2 reglatory mechanism.
Materials and Methods
Cells, cultures and control assays: Heparinized venous
blood was collected from adult donors (Transfusion
Centre, Div. of Haematology, Geneva University
Hospital). MNC were prepared by centrifugation
over a Ficoll-Paque gradient (Pharmacia). T-cell-
and B-cell-enriched populations were obtained by
rosetting with sheep erythrocytes as described.
B-lymphocytes were then isolated as described. PB
monocytes were obtained by a 2 h plastic adherence
step of the remaining MNC following the removal
of the majority of the T- and B-lymphocytes.
Highly enriched T-cell subsets were isolated from
rosette-forming cells using mAb-coated immuno-
magnetic beads (Dynabeads, Dynal) as recom-
mended by the manufacturers; for the general
method see Ref. 6. Briefly, we chose to positively
select CD4+CD8 cells with anti-CD4 mAb and,
from the remaining T-cells, CD8+CD4- cells with
anti-CD8 mAb-coated magnetic beads (in each
separation using at least five beads/cell). The purity
of the positively-selected as well as the. remaining
T-cell populations was monitored by FACS in an
EPICS V Profile Analyser (Coulter Electronics,
operated by D. Wohlwend, Geneva Medical Centre)
using the following mAb: PE-conjugated mouse
anti-human CD4 mAb (DAKO A/S), FITC-
conjugated mouse anti-human CD8 mAb (DAKO
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A/S), FITC-conjugated mouse anti-Leu 12 (CD19)
mAb (Becton Dickinson) and FITC-conjugated
goat anti-human lg (H and L chains) Ab
(Boehringer). If the purity was not satisfactory, the
positive selections were repeated on the already
selected cells. At least 107 cells are used per group
for extraction of putative TFs.
All cells were cultured as described, All T-cell
subsets were stimulated by 4h culture in the
presence of 5/g ml-1 PHA and 10 ng ml-1 PMA
at a density of 106 cells/ml. All cells used in this
study were assayed for IL-2 secretion using a
bioassay measuring proliferation of CTLL-2 cells as
described in Ref 7.
Salt-extracted S IO0 proteins (SESIO0): The protein
extracts used for injections into oocytes were
prepared as described, with the modifications
introduced in Ref. 4. Proteins attached to chromatin
were eluted by adjusting salt concentration to
300 mM before centrifugation at 100 000 g. The
protein concentration was determined using the
Bradford assay (BioRad).
Gene clones: As target gene for the trans-activation
experiments we used a construct under the control
of four copies of the IL-2 Pud element linked to a
truncated thymidine kinase promoter and a
chloramphenicol acetyl transferase (CAT) coding
unit. 2’4 The activity of this marker gene was
measured by CAT assays as described in Ref 9.
Xenopus oocyte injection: Oocyte manipulations and
injection techniques, including relevant references,
are described in detail elsewhere.1 DNA concentra-
tion was chosen on the ground of preliminary
experiments which showed that the IL-2 gene
displays a basal activity within a range of 1-10 ng
of injected DNA per nucleus, with a maximum
around 5ng. To observe both silencing and
simulation of transcription, we used 2ng of
IL-2DNA per oocyte nucleus. The injection
protocols employed in this work are: (1) Cyto-
plasmic injection of proteins, lag of 3 h to allow for
migration of nuclear proteins to the germinal
vesicle, followed by nuclear injection of DNA. (2)
Cytoplasmic injection of proteins, lag of 3 h to
allow for migration of nuclear proteins to the
germinal vesicle, injection ofDNA into the nucleus,
followed immediately by a second cytoplasmic
injection of the same or different protein extracts.
The injected oocytes were incubated for 20-24 h at
20C and protein was isolated from batches of 10-15
healthy oocytes as described.
DNA-protein binding assays: Bandshift analyses were
performed as described in Ref 11. Three g of
protein extracts were incubated with 5 000 cpm
(usually about 60-140 pg) DNA radiolabelled probe
in the presence of 0.5/g poly(dldC) nonspecific
,b
c+ arCDe
FIG. 1. Purity of T-cell subsets. T-cells were isolated from peripheral
blood and subpopulations thereof were purified by positive selection
using immunomagnetic beads coated with anti-CD4 or anti-CD8 mAb.
FACS analysis confirms purity of 96% for CD4+CD8 (a) and 99%
for CD8+CD4 (b). These results are from a representative experiment.
competitorDNA per #g of protein used. As a probe
we used chemically synthesized double stranded
oligonucleotides corresponding to the promoter
element located between positions -292 and
-264 upstream of the IL-2 cap site. Labelling was
done by elongation with Klenow polymerase. For
competition experiments we used unlabelled Pud
oligonucleotide. The competitor was mixed in
20-fold excess with the labelled probe before the
addition of the proteins. After 15 min incubation
in the presence of the proteins at R.T., the samples
were fractionated on 4% nondenaturing poly-
acrylamide gels at 10 V/cm at R.T.
Results
T-cell subsets isolatedfrom PBMC and their ability to secrete
IL-2: Using immunomagnetic beads coated with the
appropriate mAb, we were able to isolate by
positive selection two subsets of T-cells:
CD4+CD8- and CD8+CD4- (Fig. 1). The average
proportion of each T-cell subset in total peripheral
T-cells in blood has been determined with samples
from 20 donors. It is 50-60% for the CD4+CD8
group, 30-40% for CD8+CD4- group and 10-20%
for the remaining cells reacting with neither mAb
(-/-). To ensure that all cells were resting at the
Table 1. IL-2 secretion from mitogen-induced
peripheral blood T-cell subsets
Cell type % purity L-2 secretion
(U/ml/106 cells)
Total T- 86 190
CD4 96 102
CD8 + 95 14
CD8-CD4- 90 15
E + T-cells were isolated from blood and then CD4+
and CD8 + cells positively selected using mAb-
coated magnetic particles. Total T-, CD4 +, CD8 +
and the remaining non-reactive (CD4-CD8-) cells
were tested for purity by FACS. 106 cells/ml per
group were cultured with PHA/PMA for 36 h and
then their culture supernatants were collected and
assessed for L-2 biological activity by a prolifera-
tion assay of the mouse cytotoxic T-cell line CTLL
2 as described.
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FIG. 2. In vitro DNA-protein interaction. Bandshift assays were carried
out with a labelled oligonucleotide corresponding to the Pud-element
(NF-AT binding site) and with proteins from resting (R) or cells activated
(A) for 4h with PHA/PMA. Symbols are: , probe alone; CD4:
CD4+CD8-; CD8: CD8+CD4-; -/-: CD4-CD8- cells. A, left to the
panel, indicates the retarded complexes formed by putative positive TFs,
S, with silencer proteins.
I 2 3
FIG. 3. Specificity of TFs present in T-cell subsets. The same proteins as
in Fig. 2 were used. In addition, extracts of B-cells and monocytes (M,)
from two independent donors were tested. Specificity of binding was
verified by competition with a 20-fold excess of cold Pud DNA (Ac, Rc).
Numbers on top of each plate refer to lanes commented in the text.
beginning of the study, we incubated them O/N in
plain culture medium.
Equal amounts of cells from these groups were
tested for their ability to secrete IL-2 following
stimulation with PHA/PMA, by monitoring the
growth induced by addition of their supernatant on
CTLL-2 cells. The results (Table 1) show that the
CD4+CD8 cells are the main secretors while the
remaining two subsets secrete only trace amounts
of IL-2, provided the low units recorded were not
contributed by the few contaminating CD4+CD8-
cells present in these samples. No IL-2 secretion
was detectable in supernatants of B-cells and
monocytes (not shown).
In vitro DNA binding of TFs to the Pud element: The
presence of IL-2 specific TFs in different T-cell
subsets and control cells has been assessed by
DNA-protein binding (bandshift) assays. Since, in
primary mouse T-cells, the main switch of IL-2
regulation, i.e. the switching from negative to
positive, acts through the Pud element, we used
as a probe for the bandshift experiments an
oligonucleotide corresponding to both mouse and
human Pud element located at positions -290 to
-263 in the latter.
3 Protein extracts from resting
or mitogen-stimulated cells recovered from the
different cell populations were tested for the
presence of proteins that bind in vitro to this control
element.
The results (Figs 2 and 3) show that resting
CD4+CD8- cells contain large amounts of protein
that form two bands migrating closely together
(Fig. 2, lane 2). By comparison with the relative
migration of DNA-protein complexes from mouse
material,
4 these bands may be formed by silencer-
like proteins. Indeed, upon mitogenic stimulation
they disappear, and other Pud-binding proteins
appear that form two slower migrating complexes
(lane 3) that are most probably due to positive TFs.
The resting double negative ceils contain silencer-
like molecules (lane 4) but form no positive TF
upon activation (lane 5). By contrast, both resting
and mitogen stimulated CD8+CD4- cells form
only activator-like complexes (lanes 6 and 7).
As far as the above proteins are concerned, Fig.
3 gives similar results and, in addition, shows that
binding of the silencer to the labelled Pud element
is fully competed out by the addition of a 20-fold
excess of cold Pud oligonucleotides (cf. lanes 2/3).
Also the lower of the positive TF complexes is
eflqciently competed, whereas the slow migrating
complex may be nonspecific as it is poorly competed
out (cf. lanes 4/5, 6/7, 8/9). Figure 3 also shows that
B-cells (lanes 10/11) and monocytes (lanes 12/13)
completely lack Pud-specific DNA binding pro-
teins.
Functional tests of TFs in the Xenopus oocyte: In vitro
DNA-binding of a protein, as monitored in
bandshift experiments, does not necessarily imply
that the binding factor is functionally active in vivo.
Therefore, the same protein extracts isolated from
the different cell types were also assayed for their
functional activity in the Xenopus oocyte. Using this
system, we have previously shown4 that proteins
from resting mouse T-cells eciently silence basal
transcription of the injected IL-2 gene, whereas
proteins from mitogen-activated cells do not
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FIG. 4. Functional tests of TFs in the oocyte system. Proteins (5 ng) from
the different T-cell subsets in their resting (R) or activated (A) phase,
were injected into the oocyte cytoplasm, followed by injection of 2 ng of
4 Pud-CAT gene constructs into the oocyte nucleus. For the
CD4/CD8 group, following injection of silencer and the gene, extract
from activated cells was added in a third, cytoplasmic, injection to test
for derepression (R/A). The symbols used for protein extracts are the
same as in Fig. 2. CAT assays yield three forms of acetylated
chloramphenicol (lowest spot, not converted; second spot, 1-; third,
3-, fourth; 1-3-acetylation). Activity was measured on aliquots
corresponding to one oocyte taken from lysates produced from 10-15
oocytes.
silence, but fully derepress previously silenced
genes.
The tests (Fig. 4) which were carried out with a
target gene composed of 4X the Pud promoter
element and a CAT coding segment, show that the
silencer in resting CD4+CD8- cells is fully effective
in suppressing the basal activity of this promoter
(Fig. 4, cf. lanes 1 and 2). Activated CD4+CD8
cells contribute a positive TF that does not silence
basal activity (lane 3) and efficiently derepresses the
IL-2 promoter silenced by a first dose of resting cell
extracts (lane 4). As expected, resting CD8+cD4-
cells that do not contain silencer-like binding
factors, are not repressing basal IL-2 transcription.
Though some of the sample is lost, full
chloramphenicol conversion can still be observed
(lane 5). Not surprisingly, no silencing activity is
exerted by B-cell extracts (lanes 7 and 8).
purine-rich box situated between positions -292
to -264 upstream of the cap site and that, upon
cellular induction, a positive TF derepresses the
gene.
4 We looked for these regulatory factors in
human T-cells from peripheral blood and found
that they exist and also bind to the Pud promoter
element. Comparing the formation of DNA-protein
complexes by extracts from resting and mitogen-
stimulated cells, and their functional activity in the
transcription assay with our former observations
using mouse material, we may conclude that the
faster migrating complex(es) in the band shift assays
are formed by silencer molecules, whereas the two
slower migrating complexes comprise positive TFs.
Whether we observe here the two subunits of the
NF-AT described recently by Flanagan et al.,
12
remains to be seen. What can be ascertained, is that
none of these positive TFs (or the silencer) appear
in B-cells or monocytes and they thus seem to be
tissue-specific.
Interestingly, only the CD4+CDS- contain both
a functional silencer in their resting state and an
active positive TF following activation. The
CD8 +CD4- cells that contain only positive TF-like
molecules in either activity phase, are not secreting
IL-2 and this TF seems thus not to be functional.
In view of recent findings on positive TF function
involving controlled nuclear targeting,
12 it is not
easy to verify, whether the positive TF-like protein
present in these cells is functional alone, whether it
is in an inactive configuration or whether
a normal silencer is needed to help building up
positive pre-initiation complexes. Such questions
will be addressed in a later study.
Conclusively, we have shown that, among the
peripheral T-cells in human adult blood, only the
CD4+CD8 helper inducer cells contain both
functional components regulating IL-2 transcrip-
tion. This mechanism, as shown here for the first
time for human IL-2, includes a silencer present in
resting cells that inactivates the gene by binding to
the Pud element, and positive TFs derepressng the
IL-2 promoter by interacting to the same element.
Discussion
IL-2 expression was monitored in distinct subsets
of T-cells in human peripheral blood and compared
with the presence and functional state of TFs
controlling the off/on switch in IL-2 gene
transcription. Our data support the mainstream
notion that the major IL-2 secretors are the
activated CD4+CDs- cells and show that they are
the only cells to possess both functional silencer and
positive TF controlling the IL-2 gene.
In a previous study, we showed that in mouse
resting splenic T-cells the IL-2 gene is silenced
through the attachment of a silencer protein on the
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